周一，Jefferies对Quest Diagnostics (NYSE:DGX)启动覆盖，给予买入评级，目标价为185.00美元。这家医疗诊断公司目前交易价格为158.20美元，接近其52周高点165.32美元，年初至今回报率为16.58%。尽管Quest Diagnostics尚未恢复到COVID-19疫情高峰时期的最高收入水平，但公司年初至今的表现清楚地表明，在不久的将来有望超越这一基准。

LifeLabs, the Palo Alto, California-based material science company founded in a Stanford University laboratory, has been ...

A long-withheld investigation into a 2019 hacking at LifeLabs Inc. that compromised millions of Canadians’ health data has finally been made public after an Ontario court dismissed the company ...

LifeLabs, the material science company founded in a Stanford University laboratory, has been awarded the prestigious Best ...

SUNNYVALE - US sustainable textile start-up LifeLabs has developed an ultra-packable and breathable fabric that as well as ...

In 2022, Canada saw a 25 per cent increase in HIV cases. Find out why HIV testing is important and how you can get a test ...

LifeLabs pursued a judicial review of the commissioners’ decision, but Ontario’s Divisional Court upheld the findings, ruling ...

A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational purposes.

Police believe there could be more victims of a Burlington woman accused in a scam targeting Taylor Swift fans who were ...